Found: 14
Select item for more details and to access through your institution.
Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 5, p. 745, doi. 10.1007/s00432-012-1155-9
- By:
- Publication type:
- Article
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 2, p. 403, doi. 10.1007/s10147-013-0561-6
- By:
- Publication type:
- Article
Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055637
- By:
- Publication type:
- Article
Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 348, doi. 10.1111/bcp.12149
- By:
- Publication type:
- Article
Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 4, p. 919, doi. 10.1111/j.1365-2125.2012.04417.x
- By:
- Publication type:
- Article
Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Lung, 2012, v. 190, n. 5, p. 477, doi. 10.1007/s00408-012-9399-3
- By:
- Publication type:
- Article
The Role of Vandetanib in the Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Four Randomized Controlled Trials.
- Published in:
- Lung, 2011, v. 189, n. 6, p. 437, doi. 10.1007/s00408-011-9332-1
- By:
- Publication type:
- Article
The Prognostic Value of Survivin Expression in Patients with Colorectal Carcinoma: A Meta-analysis.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 10, p. 988, doi. 10.1093/jjco/hyt103
- By:
- Publication type:
- Article
Efficacy and Safety of Gemcitabine–Docetaxel Combination Therapy for Recurrent or Refractory High-grade Osteosarcoma in China: A Retrospective Study of 18 Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 5, p. 427
- By:
- Publication type:
- Article
Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 431, doi. 10.1007/s00280-012-2025-5
- By:
- Publication type:
- Article
Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 12, p. 2967, doi. 10.1002/ijc.27979
- By:
- Publication type:
- Article
Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: An updated meta-analysis of ten randomized controlled trials.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 2, p. E66, doi. 10.1002/ijc.27775
- By:
- Publication type:
- Article
Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
- Published in:
- Journal of Molecular Medicine, 2019, v. 97, n. 1, p. 49, doi. 10.1007/s00109-018-1711-0
- By:
- Publication type:
- Article
Evaluation of pirarubicin-cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute.
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2229, doi. 10.1007/s12032-011-0021-y
- By:
- Publication type:
- Article